Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2023 earnings call. At this time, all participants are on a listen-only mode. Later, we will be conducting a question ...

Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 ...

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks Consensus Estimate of $5.03 per share. Earnings rose 114% year over year.

Eli Lilly (NYSE:LLY) on Thursday reported its Q4 2024 results, exceeding Wall Street forecasts and indicating a more than twofold rise in revenue from its weight loss and obesity drugs Mounjaro ...

Eli Lilly's Q4 revenue rose 45% YoY to $13.53B ... Price Action: At last check on Thursday, LLY stock was up 1.11% at 851.49 during the premarket session.